We are live on ! Find out more
APTO

Aptose Biosciences, Inc.
APTO

Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

21 hedge funds and large institutions have $3.29M invested in Aptose Biosciences, Inc. in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

117% more capital invested

Capital invested by funds: $1.52M → $3.29M (+$1.77M)

31% more funds holding

Funds holding: 16 → 21 (+5)

Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$646K
2
DS
DRW Securities
Illinois
+$368K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$156K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$70.1K
5
PFGIA
Patriot Financial Group Insurance Agency
Massachusetts
+$59K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$102K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$27K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$6.38K
4
Wells Fargo
Wells Fargo
California
-$3K

APTO Hedge Fund Activity: Q2 2018 in Review

21 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q2 2018, worth a combined $3.29M — up 117% from $1.52M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new APTO positions and 2 closed out — a net gain of 6 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $646K. The largest seller was Deutsche Bank, cutting an estimated $102K.

  • 21 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q2 2018, up from 16 in Q1 2018.
  • Funds reported $3.29M of Aptose Biosciences, Inc. stock for Q2 2018, up 117% quarter-over-quarter.
  • 8 funds opened new Aptose Biosciences, Inc. positions in Q2 2018 and 2 closed out, a net change of +6 holders.
  • The largest Aptose Biosciences, Inc. buyer in Q2 2018 was Morgan Stanley, an estimated $646K added.
  • The largest Aptose Biosciences, Inc. seller in Q2 2018 was Deutsche Bank, an estimated $102K sold.

Based on aggregated 13F filings for Q2 2018.